Sign in to follow this  
Followers 0
Joelf

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation (AHSCT) in systemic sclerosis patients?

1 post in this topic

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation (AHSCT) in systemic sclerosis patients?

 

We demonstrate that CD34+ does not add benefit to the outcome of SSc patient treated with AHSCT and these findings should be further confirmed by prospective randomized trials. PubMed, Bone Marrow Transplant, 12/07/2015. (Also see Stem Cell (Bone Marrow) Transplantation)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde

ISN Assistant Webmaster

SD World Webmaster

ISN Sclero Forums Manager

ISN News Manager

ISN Hotline Support Specialist

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0